@article{TAU6749,
author = {Yaron Ehrlich and David Margel and Marc Alan Lubin and Jack Baniel},
title = {Advances in the treatment of testicular cancer},
journal = {Translational Andrology and Urology},
volume = {4},
number = {3},
year = {2015},
keywords = {},
abstract = {Germ cell tumors (GCT) are relatively uncommon, accounting for only 1% of male malignancies in the United States. It has become an important oncological disease for several reasons. It is the most common malignancy in young men 15-35 years old. GCTs are among a unique numbers of neoplasms where biochemical markers play a critical role. Finally, it is a model of curable cancer. In this review we discuss cancer epidemiology, genetics, and therapeutic principles. Recent advances in the management of stage I GCT and controversies in the management of post chemotherapy residual mass are presented.},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/6749}
}